The OncoDaily Gallbladder and Bile Duct Cancer Summit 2026 is a global virtual medical congress dedicated entirely to gallbladder and bile duct cancers, focusing on screening, early diagnosis, multidisciplinary treatment strategies, and future directions in prevention and disease control.
Taking place on February 28, during Gallbladder and Bile Duct Cancer Awareness Month, the summit brings together leading experts from across continents to discuss current standards of care, emerging therapies, precision medicine approaches, and evolving clinical practices shaping the future of hepatobiliary oncology.
How I Treat Gallbladder and Bile Duct Cancer in 2026 https://t.co/TFOiuARthB
— OncoDaily (@oncodaily) February 28, 2026
How I Treat Gallbladder and Bile Duct Cancer in 2026 https://t.co/KiCMsxZedh
— OncoDaily (@oncodaily) February 28, 2026
How I Treat Gallbladder and Bile Duct Cancer in 2026 https://t.co/YtRtWrz5aw
— OncoDaily (@oncodaily) February 28, 2026
Scientific Program Overview
This focused virtual meeting will explore the full clinical spectrum of gallbladder and biliary tract cancers, emphasizing practical, experience-based management in 2026. The program will address contemporary approaches to suspected and early-stage gallbladder cancer through risk-stratified decision-making, as well as evidence-based strategies for advanced and metastatic disease. Sessions will examine structured treatment principles that guide daily clinical practice, including systemic therapy selection, multidisciplinary coordination, and individualized patient care.
In addition, the summit will highlight evolving surgical standards, including minimally invasive and robot-assisted techniques for gallbladder and bile duct cancers. Across discussions, speakers will share real-world perspectives on optimizing outcomes, integrating innovation into practice, and shaping the future direction of hepatobiliary oncology within diverse healthcare settings worldwide.
| Images | Name | Time | Topic |
|---|---|---|---|
 | Nikhil Agrawal (India) Lead Gastrointestinal-hepatobiliary Surgical Oncologist at Apollo Hospitals Delhi & Gurugram, India | 4:30 pm | Robot‑Assisted surgery for Gallbladder and Bile‑Duct Cancers in 2026. |
 | Parandzem Khachatryan (Armenia) | 5:00pm | Modern Aspects of Morphological Diagnosis of Cholangiocarcinoma |
 | Erman Akkus (Turkey) Gastrointestinal Medical Ongolocist at Ankara Üniversitesi Tıp Fakültesi, Turkey | 6:0 pm | How I treat Biliary Tract Cancers in 2026 |
 | Lewis R. Roberts (USA) Peter and Frances Georgeson Professor in Gastroenterology Cancer Research and Consultant in Gastroenterology and Hepatology at the Mayo Clinic, Co-Chair of the Hepatobiliary Cancer Disease Group of Mayo Clinic Cancer Center, | 6:30 pm | |
 | Thatcher Heumann (USA) | 7:00 pm | Contemporary Systemic Therapy for Biliary Tract Cancers |
 | Vinay Kumar Kapoor (India) Professor of Surgical Gastroenterology, Pro Vice Chancellor at Mahatma Gandhi University of Medical Sciences & Technology (MGUMST), Jaipur, India | 7:30 pm | Ten Commandments in Gall Bladder Cancer |
 | Ghassan K. Abou-Alfa (USA) Gastrointestinal Ongolocist at Memorial Sloan Kettering Cancer Center, Professor of Medicine at Weill Medical College at Cornell University | 8:30 pm | How do you treat gallbladder cancer? |
 | James Harding (USA) Medical oncologist and researcher at Memorial Sloan Kettering Cancer Center (MSKCC) | 9:00 pm | Biliary Tract Cancers: Emerging HER2 and RAS Targeted Therapies |
 | Iron Pires (Brazil) Hepatobiliary and liver transplant surgeon at Universidade Federal de São Paulo (UNIFESP) | 10:10 pm | Panel Discussion |
 | Giuseppe Santabarbara (Italy) Medical Doctor of Oncology at San Giuseppe Moscati National Hospital | 10:10 pm | Panel Discussion |
The OncoDaily Gallbladder and Bile Duct Cancer Summit 2026 is designed for medical oncologists, hepatobiliary surgeons, gastroenterologists, radiation oncologists, radiologists, pathologists, translational researchers, and oncology trainees seeking a practical and globally informed perspective on gallbladder and biliary tract cancer management in 2026.
The meeting emphasizes evidence-based decision-making, multidisciplinary coordination, surgical innovation, and the integration of emerging systemic therapies into real-world practice. By bringing together experts from different regions, the summit aims to address variations in access to care, diagnostic capabilities, and treatment strategies, while highlighting future directions in hepatobiliary oncology.
Event Details
Date: February 28, 2026
Format: Virtual Global Summit
Registration: Link to Register
Live Streaming: LinkedIn | YouTube | X
A dedicated day focused on gallbladder and bile duct cancer science, clinical strategy, surgical advances, and global perspectives, featuring expert voices from across continents.